Followers | 9 |
Posts | 741 |
Boards Moderated | 0 |
Alias Born | 10/06/2010 |
Tuesday, May 10, 2011 10:45:12 PM
On a seperate note:
Anyone who thinks KBLB just sitting on their thumbs,or are too quiet or not for real.... Think again.
All SEC filings in order.
University of Notre Dame's support.
Board of Advisors (unchallenged by the way) with connections to Dupont,Glaxosmith, huge international business expertise.
Press releases, Press conference at NotreDame on scientific breakthrough, conference call, year end letter to shareholders,
licensing deal completed with direction of medical uses already negotiated.
Proof of Trademarks filed for commercial use.
SIGMA Aldrich's involvement with us/investment in us.
Pre notice of CC/details.
As others have said, look for reasons not to invest in KBLB....
oh yeah, they bring in no income. So weigh the thought of losing a .10 cent a share stock that goes nowhere versus the potential of where a .10 stock will go with all this momentum and leadership behind it. Hmmmm...
I am and have been long with KBLB so I always try to reserve my cheerleading and just post info, but sometimes I can't help myself.
GO KBLB!
All this is JMHO.
-Posting this again to correct wording at the top.
Everything I say is my own opinion and should not be taken as direct investment advice. Do your own DD and make your own decisions.
Recent KBLB News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/04/2024 04:15:03 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • SONGD • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM